Galderma Group AG (GDERF)
239.95
+9.09
(+3.94%)
USD |
OTCM |
Oct 26, 16:00
Galderma Group Market Cap : 55.95B for Oct. 26, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 26, 2026 | 55.95B |
| October 23, 2026 | 53.83B |
| October 22, 2026 | 51.33B |
| October 21, 2026 | 51.52B |
| October 20, 2026 | 49.40B |
| October 19, 2026 | 51.36B |
| October 16, 2026 | 51.43B |
| October 15, 2026 | 50.53B |
| October 14, 2026 | 46.12B |
| October 13, 2026 | 45.20B |
| October 12, 2026 | 49.18B |
| October 09, 2026 | 44.77B |
| October 08, 2026 | 47.57B |
| October 07, 2026 | 44.04B |
| October 06, 2026 | 47.60B |
| October 05, 2026 | 46.32B |
| October 02, 2026 | 44.16B |
| October 01, 2026 | 44.15B |
| September 30, 2026 | 44.68B |
| September 29, 2026 | 44.66B |
| September 28, 2026 | 43.79B |
| September 25, 2026 | 44.63B |
| September 24, 2026 | 47.48B |
| September 23, 2026 | 47.92B |
| September 22, 2026 | 48.56B |
| Date | Value |
|---|---|
| September 21, 2026 | 45.71B |
| September 18, 2026 | 46.61B |
| September 17, 2026 | 46.64B |
| September 16, 2026 | 43.26B |
| September 15, 2026 | 43.26B |
| September 14, 2026 | 44.58B |
| September 11, 2026 | 42.88B |
| September 10, 2026 | 43.61B |
| September 09, 2026 | 47.25B |
| September 08, 2026 | 49.21B |
| September 04, 2026 | 46.17B |
| September 03, 2026 | 46.17B |
| September 02, 2026 | 49.37B |
| September 01, 2026 | 48.27B |
| August 31, 2026 | 48.44B |
| August 28, 2026 | 48.15B |
| August 27, 2026 | 48.04B |
| August 26, 2026 | 52.07B |
| August 25, 2026 | 51.25B |
| August 24, 2026 | 47.98B |
| August 21, 2026 | 51.84B |
| August 20, 2026 | 47.81B |
| August 19, 2026 | 51.02B |
| August 18, 2026 | 49.47B |
| August 17, 2026 | 47.82B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Novartis AG | 281.56B |
| Roche Holding AG | 331.13B |
| Addex Therapeutics Ltd. | 3.079M |
| Oculis Holding AG | 491.39M |
| Sandoz Group AG | 43.13B |
Market Cap Related Metrics
| PE Ratio | 65.53 |
| PS Ratio | 9.598 |
| Price to Free Cash Flow | 53.31 |
| Price | 239.95 |
| Earnings Yield | 1.53% |
| Operating PE Ratio | 51.80 |
| Normalized PE Ratio | 61.17 |